Free Trial

Cresco Labs (CRLBF) Stock Price, News & Analysis

-0.05 (-2.70%)
(As of 05/29/2024 ET)
Today's Range
50-Day Range
52-Week Range
445,913 shs
Average Volume
978,463 shs
Market Capitalization
$616.82 million
P/E Ratio
Dividend Yield
Price Target

Cresco Labs MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.60 Rating Score
788.9% Upside
$16.00 Price Target
Short Interest
0.53% of Shares Sold Short
Dividend Strength
News Sentiment
0.81mentions of Cresco Labs in the last 14 days
Based on 3 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.04) to $0.01 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.53 out of 5 stars

CRLBF stock logo

About Cresco Labs Stock (OTCMKTS:CRLBF)

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

CRLBF Stock Price History

CRLBF Stock News Headlines

Jefferies Remains a Buy on Cresco Labs (CRLBF)
See More Headlines
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Medicinals & botanicals
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$770.89 million
Cash Flow
$0.05 per share
Book Value
$1.23 per share


Free Float
Market Cap
$616.82 million
Not Optionable
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Charles Bachtell (Age 45)
    Co-Founder, CEO & Director
    Comp: $999.85k
  • Mr. Robert M. Sampson (Age 49)
    Co-Founder & Independent Director
  • Mr. Dennis M. Olis (Age 61)
    Chief Financial Officer
    Comp: $622.85k
  • Mr. Gregory Butler (Age 43)
    President & Chief Transformation Officer
  • Mr. Ty Gent (Age 65)
    Chief Operating Officer
  • Mr. Zach Marburger (Age 39)
    Chief Information Officer
  • Ms. Megan Kulick
    Senior Vice President of Investor Relations
  • Mr. John Schetz (Age 46)
    General Counsel
  • Mr. Jason Erkes (Age 53)
    Chief Communications Officer
  • Ms. Angie Demchenko (Age 43)
    Chief People Officer

CRLBF Stock Analysis - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRLBF shares.
View CRLBF analyst ratings
or view top-rated stocks.

What is Cresco Labs' stock price target for 2024?

5 equities research analysts have issued 1-year price targets for Cresco Labs' stock. Their CRLBF share price targets range from $2.00 to $34.00. On average, they expect the company's share price to reach $16.00 in the next year. This suggests a possible upside of 788.9% from the stock's current price.
View analysts price targets for CRLBF
or view top-rated stocks among Wall Street analysts.

How have CRLBF shares performed in 2024?

Cresco Labs' stock was trading at $1.3558 at the beginning of 2024. Since then, CRLBF shares have increased by 32.8% and is now trading at $1.80.
View the best growth stocks for 2024 here

How were Cresco Labs' earnings last quarter?

Cresco Labs Inc. (OTCMKTS:CRLBF) posted its earnings results on Wednesday, May, 15th. The company reported ($0.02) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.02). The company had revenue of $184.30 million for the quarter, compared to the consensus estimate of $183.31 million. Cresco Labs had a negative trailing twelve-month return on equity of 6.78% and a negative net margin of 20.32%.

How do I buy shares of Cresco Labs?

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CRLBF) was last updated on 5/30/2024 by Staff

From Our Partners